📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

MatsukiyoCocokara & Co

Country
Japan
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
12,753
Ticker
3088
Exchange
TOKYO STOCK EXCHANGE
Description
Matsukiyococokara & Co. is a prominent entity within the retail sector, operating as a major drugstore chain in Japan. This asset primarily serves the consumer market through its extensive network of ...

MatsukiyoCocokara & Co's Financial Statements Preview

Below are the financial statements of MatsukiyoCocokara & Co, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in trillions of JPY
2024
2023
2022
2021
2020
2019
Business results——————
Net sales
1.02a
0.95a
0.73a
0.54a
0.59a
0.58a
Cost of sales
-0.67a
-0.62a
-0.49a
-0.37a
-0.4a
-0.4a
Selling, general, and administrative expenses
-0.28a
-0.27a
-0.2a
-0.14a
-0.15a
-0.14a
Operating profit
0.08a
0.06a
0.04a
0.03a
0.04a
0.04a
EBITDA
0.1a
0.08a
0.06a
0.04a
0.05a
0.04a
Net profit for the year
0.05a
0.04a
0.03a
0.02a
0.03a
0.03a
Download Data

Verified Sources Behind MatsukiyoCocokara & Co’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore MatsukiyoCocokara & Co’s data sources below and access millions more through our Disclosure Search.

a. MatsukiyoCocokara & Co's Integrated Report 2024
a. MatsukiyoCocokara & Co's Integrated Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?